Perphenazine - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for perphenazine and what is the scope of freedom to operate?

Perphenazine is the generic ingredient in two branded drugs marketed by Pharm Assoc, Schering, Ani Pharms, Appco, Endo Operations, Macleods Pharms Ltd, Mylan, Rising, Sandoz, Watson Labs Inc, Wilshire Pharms Inc, and Zydus Pharms, and is included in nineteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for perphenazine. Sixteen suppliers are listed for this compound.

Summary for perphenazine

US Patents:	0
Tradenames:	2
Applicants:	12
NDAs:	19
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	16
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	27
Patent Applications:	7,143
Drug Prices:	Drug price trends for perphenazine
What excipients (inactive ingredients) are in perphenazine?	perphenazine excipients list
DailyMed Link:	perphenazine at DailyMed

See drug prices for perphenazine

Recent Clinical Trials for perphenazine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Guadalajara	Phase 2
Institute of Experimental and Clinical Therapeutics	Phase 2
Hospital Civil de Guadalajara	Phase 2

See all perphenazine clinical trials

Pharmacology for perphenazine

Drug Class	Phenothiazine

Medical Subject Heading (MeSH) Categories for perphenazine

Antipsychotic Agents
Dopamine Antagonists

Anatomical Therapeutic Chemical (ATC) Classes for perphenazine

N05AB	Phenothiazines with piperazine structure
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for perphenazine

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	PERPHENAZINE	perphenazine	TABLET;ORAL	205056-002	Mar 1, 2019	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Macleods Pharms Ltd	PERPHENAZINE	perphenazine	TABLET;ORAL	212545-003	May 6, 2024	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Schering	TRILAFON	perphenazine	TABLET;ORAL	010775-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.